Literature DB >> 32103708

Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.

Elia Sechi1, Karl N Krecke2, Sean J Pittock3, Divyanshu Dubey3, A Sebastian Lopez-Chiriboga4, Amy Kunchok1, Brian G Weinshenker1, Nicholas L Zalewski1, Eoin P Flanagan3.   

Abstract

BACKGROUND: Myelitis accompanied by a negative spinal cord MRI may lead to diagnostic uncertainty. OBJECTIVE AND METHODS: We retrospectively investigated the frequency of negative spinal cord MRI (performed <6 weeks from onset) in Mayo Clinic patients with myelin oligodendrocyte glycoprotein (MOG)-IgG-associated myelitis (2000-2019).
RESULTS: The initial spinal cord MRI was negative in 7/73 (10%) patients, despite severe acute disability (median EDSS, 7 (range, 4.5-8)); myelitis symptoms/signs were frequent (paraparesis, neurogenic bladder, sensory level, Lhermitte's phenomenon). Myelitis lesions became overt at follow-up MRI in three patients.
CONCLUSIONS: A negative spinal cord MRI should not dissuade from MOG-IgG testing in patients with acute/subacute myelitis.

Entities:  

Keywords:  Demyelination; MRI; T2 lesions; acute transverse myelitis; myelin oligodendrocyte glycoprotein; neuromyelitis optica

Year:  2020        PMID: 32103708      PMCID: PMC7500857          DOI: 10.1177/1352458520907900

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  12 in total

1.  MOG-related disorders: A new cause of imaging-negative myelitis?

Authors:  Gabrielle Macaron; Daniel Ontaneda
Journal:  Mult Scler       Date:  2019-04-01       Impact factor: 6.312

2.  Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Authors:  Divyanshu Dubey; Sean J Pittock; Karl N Krecke; Padraig P Morris; Elia Sechi; Nicholas L Zalewski; Brian G Weinshenker; Eslam Shosha; Claudia F Lucchinetti; James P Fryer; A Sebastian Lopez-Chiriboga; John C Chen; Jiraporn Jitprapaikulsan; Andrew McKeon; Avi Gadoth; B Mark Keegan; Jan-Mendelt Tillema; Elie Naddaf; Marc C Patterson; Kevin Messacar; Kenneth L Tyler; Eoin P Flanagan
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

3.  Relapsing lumbosacral myeloradiculitis: An unusual presentation of MOG antibody disease.

Authors:  Soumya Sundaram; Sruthi S Nair; Deepasree Jaganmohan; Gopikrishnan Unnikrishnan; Muralidharan Nair
Journal:  Mult Scler       Date:  2019-04-01       Impact factor: 6.312

4.  Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Authors:  Elia Sechi; P Pearse Morris; Andrew McKeon; Sean J Pittock; Shannon R Hinson; Brian G Weinshenker; Allen J Aksamit; Karl N Krecke; Timothy J Kaufmann; Evan A Jolliffe; Nicholas L Zalewski; Anastasia Zekeridou; Dean M Wingerchuk; Jiraporn Jitprapaikulsan; Eoin P Flanagan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-07-21       Impact factor: 10.154

Review 5.  Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues.

Authors:  E P Flanagan; A McKeon; V A Lennon; J Kearns; B G Weinshenker; K N Krecke; M Matiello; B M Keegan; B Mokri; A J Aksamit; S J Pittock
Journal:  Neurology       Date:  2011-06-14       Impact factor: 9.910

6.  Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria.

Authors:  Nicholas L Zalewski; Alejandro A Rabinstein; Karl N Krecke; Robert D Brown; Eelco F M Wijdicks; Brian G Weinshenker; Timothy J Kaufmann; Jonathan M Morris; Allen J Aksamit; J D Bartleson; Giuseppe Lanzino; Melissa M Blessing; Eoin P Flanagan
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

7.  Delayed MR imaging changes in acute disseminated encephalomyelitis.

Authors:  J Honkaniemi; P Dastidar; V Kähärä; H Haapasalo
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

8.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

9.  Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.

Authors:  Elia Sechi; Eslam Shosha; Jonathan P Williams; Sean J Pittock; Brian G Weinshenker; B Mark Keegan; Nicholas L Zalewski; Alfonso Sebastian Lopez-Chiriboga; Jiraporn Jitprapaikulsan; Eoin P Flanagan
Journal:  Neurology       Date:  2019-06-24       Impact factor: 11.800

10.  MRI-Negative Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Antibody Spectrum Demyelinating Disease.

Authors:  Carlos A Pérez; Stephanie Garcia-Tarodo; Regina Troxell
Journal:  Child Neurol Open       Date:  2019-02-17
View more
  15 in total

1.  COVID-19 Vaccine-A Potential Trigger for MOGAD Transverse Myelitis in a Teenager-A Case Report and a Review of the Literature.

Authors:  Cristina Oana Mărginean; Lorena Elena Meliț; Maria Teodora Cucuiet; Monica Cucuiet; Mihaela Rațiu; Maria Oana Săsăran
Journal:  Children (Basel)       Date:  2022-05-06

Review 2.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.

Authors:  Elia Sechi; Laura Cacciaguerra; John J Chen; Sara Mariotto; Giulia Fadda; Alessandro Dinoto; A Sebastian Lopez-Chiriboga; Sean J Pittock; Eoin P Flanagan
Journal:  Front Neurol       Date:  2022-06-17       Impact factor: 4.086

Review 3.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

Review 4.  Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management.

Authors:  Elia Sechi; Eoin P Flanagan
Journal:  Front Neurol       Date:  2021-07-07       Impact factor: 4.003

5.  Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS.

Authors:  Samantha A Banks; Padraig P Morris; John J Chen; Sean J Pittock; Elia Sechi; Amy Kunchok; Jan-Mendelt Tillema; James P Fryer; Brian G Weinshenker; Karl N Krecke; A Sebastian Lopez-Chiriboga; Adam Nguyen; Tammy M Greenwood; Claudia F Lucchinetti; Nicholas L Zalewski; Steven A Messina; Eoin P Flanagan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-12-28       Impact factor: 13.654

Review 6.  Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD).

Authors:  Yunjie Li; Xia Liu; Jingxuan Wang; Chao Pan; Zhouping Tang
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750

7.  Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions.

Authors:  Rafid Mustafa; Theodore J Passe; Alfonso S Lopez-Chiriboga; Brian G Weinshenker; Karl N Krecke; Nicholas L Zalewski; Felix E Diehn; Elia Sechi; Jay Mandrekar; Timothy J Kaufmann; Padraig P Morris; Sean J Pittock; Michel Toledano; Giuseppe Lanzino; Allen J Aksamit; Neeraj Kumar; Claudia F Lucchinetti; Eoin P Flanagan
Journal:  Neurol Clin Pract       Date:  2021-10

8.  Refractory Longitudinally Extensive Transverse Myelitis after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in a Japanese Man.

Authors:  Noriyuki Miyaue; Akira Yoshida; Yuki Yamanishi; Satoshi Tada; Rina Ando; Yuko Hosokawa; Hayato Yabe; Masahiro Nagai
Journal:  Intern Med       Date:  2021-12-11       Impact factor: 1.271

9.  Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.

Authors:  Elia Sechi; Karl N Krecke; Steven A Messina; Marina Buciuc; Sean J Pittock; John J Chen; Brian G Weinshenker; A Sebastian Lopez-Chiriboga; Claudia F Lucchinetti; Nicholas L Zalewski; Jan Mendelt Tillema; Amy Kunchok; Salvatore Monaco; Padraig P Morris; James P Fryer; Adam Nguyen; Tammy Greenwood; Stephanie B Syc-Mazurek; B Mark Keegan; Eoin P Flanagan
Journal:  Neurology       Date:  2021-07-14       Impact factor: 9.910

Review 10.  Clinical and neuroimaging findings in MOGAD-MRI and OCT.

Authors:  Frederik Bartels; Angelo Lu; Frederike Cosima Oertel; Carsten Finke; Friedemann Paul; Claudia Chien
Journal:  Clin Exp Immunol       Date:  2021-07-18       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.